Is IMPL or SCHD a better dividend investment in 2026?

IMPL currently yields 5000.00% with a 5% 5-year dividend growth rate. SCHD yields 3.46% with 13.05% growth. The better choice depends on your goal: IMPL offers higher current income.

What is the dividend yield difference between IMPL and SCHD?

IMPL has a forward dividend yield of 5000.00% ($2.00/share annually). SCHD yields 3.46% ($1.06/share annually). The yield gap is 4996.54 percentage points.

Home › Compare › IMPL vs SCHD

IMPL vs SCHD: Dividend Comparison 2026

IMPL yields 5000.00% · SCHD yields 3.46%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IMPL wins by $62217131802825.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IMPL

● Live price

5000.00%

Share price

$0.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$62217131802825.35M

Annual income

$59,861,980,287,378,210,000.00

Full IMPL calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.46%

Share price

$30.48

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$425.95

Full SCHD calculator →

Portfolio growth — IMPL vs SCHD

📍 IMPL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IMPL	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IMPL + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IMPL pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMPL

Annual income on $10K today (after 15% tax)

$425,000.00/yr

After 10yr DRIP, annual income (after tax)

$50,882,683,244,271,480,000.00/yr

SCHD

Annual income on $10K today (after 15% tax)

$294.40/yr

After 10yr DRIP, annual income (after tax)

$362.06/yr

At 15% tax rate, IMPL beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMPL + SCHD for your $10,000?

IMPL: 50%SCHD: 50%

100% SCHD50/50100% IMPL

Portfolio after 10yr

$31108565901412.69M

Annual income

$29,930,990,143,689,105,000.00/yr

Blended yield

96.21%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMPL buys

SCHD buys

Politician	Chamber	Ticker	Type	Amount	Date
Virginia Foxx	🏢 House	$SCHD	▼ Sell	$50,001 - $100,000	2023-03-08
Steve Cohen	🏢 House	$SCHD	▲ Buy	$50,001 - $100,000	2022-07-29
Hakeem S. Jeffries	🏢 House	$SCHD	▲ Buy	$15,001 - $50,000	2021-04-12
Mikie Sherrill	🏢 House	$SCHD	▲ Buy	$100,001 - $250,000	2020-02-21

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIMPLSCHD

Forward yield	5000.00% ✓	3.46%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$62217131802825.35M ✓	$29.0K
Annual income after 10y	$59,861,980,287,378,210,000.00 ✓	$425.95
Total dividends collected	$62057786341622.61M ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IMPL vs SCHD ($10,000, DRIP)

Year	IMPL Portfolio	IMPL Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$510,700	$500,000.00	$11,226	$346.36	+$499.5K → IMPL
2	$24,410,935	$23,864,485.98	$12,572	$357.38	+$24.40M → IMPL
3	$1,092,192,501	$1,066,072,800.30	$14,046	$367.84	+$1092.18M → IMPL
4	$45,746,366,951	$44,577,720,975.17	$15,660	$377.73	+$45746.35M → IMPL
5	$1,793,932,828,410	$1,744,984,215,772.56	$17,425	$387.07	+$1793932.81M → IMPL
6	$65,871,973,805,320	$63,952,465,678,921.49	$19,354	$395.86	+$65871973.79M → IMPL
7	$2,265,146,887,602,700	$2,194,663,875,631,007.20	$21,461	$404.13	+$2265146887.58M → IMPL
8	$72,954,689,148,998,180	$70,530,981,979,263,280.00	$23,762	$411.89	+$72954689148.97M → IMPL
9	$2,201,076,182,660,884,700	$2,123,014,665,271,456,500.00	$26,272	$419.15	+$2201076182660.86M → IMPL
10	$62,217,131,802,825,350,000	$59,861,980,287,378,210,000.00	$29,010	$425.95	+$62217131802825.32M → IMPL

IMPL vs SCHD: Complete Analysis 2026

IMPL — Stock

Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. Impel Pharmaceuticals Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.

Full IMPL Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this IMPL vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMPL vs JEPI IMPL vs O IMPL vs KO IMPL vs MAIN IMPL vs VYM IMPL vs DGRO IMPL vs VIG IMPL vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.